El Cajon, CA, United States of America

Mark L Stiger

This inventor holds 33 USPTO granted patents and 21 published patent applications and 8 EPO patents. Top assignees: Medtronic Vascular, Inc., Medtronic Ave, Inc., Medronic, Inc.. Active years: 1999-2025.

USPTO Granted Patents = 33 

% Patents Active = 93.9

 

Average Co-Inventor Count = 3.0

ph-index = 8

Forward Citations = 587(Granted Patents)


Location History:

  • El Cajon, CA (US) (1999 - 2001)
  • Windsor, CA (US) (2014 - 2020)
  • Santa Rosa, CA (US) (2003 - 2023)

Company Filing History:


Years Active: 1999-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Modular Stent Assembly
Stent-Graft Prosthesis
Aortic Arch Prosthetic
Endovascular Delivery System
Bifurcating Branch Device
Guidewire with Radiopaque Markers
Brachytherapy Catheter
Intraluminal Therapy Catheter
Stent Delivery Catheter
Femoral Aortic Access
Landing Zone for Endovascular Procedures
Pressure Relief Channels
33 patents (USPTO):Explore Patents

Title: The Inventor Mark L Stiger: Pioneering Innovations in El Cajon

Introduction: Mark L Stiger is a renowned inventor based in El Cajon, California, known for his groundbreaking contributions to various industries.

Latest Patents: Mark L Stiger holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Mark L Stiger has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Mark L Stiger has collaborated with leading companies, research institutions, and universities to bring his inventions to life, fostering a culture of creativity and excellence in the industry.

Conclusion: Mark L Stiger's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of technology and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…